Biogen, Inc. (BIIB)
174.82
+0.12
(+0.07%)
USD |
NASDAQ |
Dec 23, 16:00
174.73
-0.09
(-0.05%)
After-Hours: 20:00
Biogen SG&A Expense (TTM): 2.431B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.976B |
| Eli Lilly & Co. | 10.39B |
| Merck & Co., Inc. | 10.70B |
| Pfizer Inc. | 13.91B |
| Stoke Therapeutics, Inc. | 58.79M |